These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12823911)

  • 61. Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.
    Conway SP; Watson A
    Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S64-8. PubMed ID: 9155855
    [No Abstract]   [Full Text] [Related]  

  • 62. Aerosol delivery and safety of recombinant human deoxyribonuclease in young children with cystic fibrosis: a bronchoscopic study. Pulmozyme Pediatric Broncoscopy Study Group.
    Wagener JS; Rock MJ; McCubbin MM; Hamilton SD; Johnson CA; Ahrens RC
    J Pediatr; 1998 Oct; 133(4):486-91. PubMed ID: 9787685
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nebulized hypertonic saline via positive expiratory pressure versus via jet nebulizer in patients with severe cystic fibrosis.
    O'Connell OJ; O'Farrell C; Harrison MJ; Eustace JA; Henry MT; Plant BJ
    Respir Care; 2011 Jun; 56(6):771-5. PubMed ID: 21333079
    [TBL] [Abstract][Full Text] [Related]  

  • 64. New nebulizer technology to monitor adherence and nebulizer performance in cystic fibrosis.
    McCormack P; Southern KW; McNamara PS
    J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25(6):307-9. PubMed ID: 22856641
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical trials of recombinant human DNase in cystic fibrosis patients.
    Aitken ML
    Monaldi Arch Chest Dis; 1993 Dec; 48(6):653-6. PubMed ID: 8124306
    [TBL] [Abstract][Full Text] [Related]  

  • 66. No positive effect of rhdnase on the pulmonary colonization in children with cystic fibrosis.
    Bonestroo HJ; Slieker MG; Arets HG
    Monaldi Arch Chest Dis; 2010 Mar; 73(1):12-7. PubMed ID: 20499789
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Respirable mass: vague and indefinable in disease.
    Smaldone GC; Diot P; Groth M; Ilowite J
    J Aerosol Med; 1998; 11 Suppl 1():S105-11. PubMed ID: 10180720
    [No Abstract]   [Full Text] [Related]  

  • 68. Lung deposition in cystic fibrosis patients using an ultrasonic or a jet nebulizer.
    Köhler E; Sollich V; Schuster-Wonka R; Hühnerbein J
    J Aerosol Med; 2003; 16(1):37-46. PubMed ID: 12737683
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
    King M; Dasgupta B; Tomkiewicz RP; Brown NE
    Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis.
    Paul K; Rietschel E; Ballmann M; Griese M; Worlitzsch D; Shute J; Chen C; Schink T; Döring G; van Koningsbruggen S; Wahn U; Ratjen F;
    Am J Respir Crit Care Med; 2004 Mar; 169(6):719-25. PubMed ID: 14684561
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study.
    Bilton D; Robinson P; Cooper P; Gallagher CG; Kolbe J; Fox H; Jaques A; Charlton B;
    Eur Respir J; 2011 Nov; 38(5):1071-80. PubMed ID: 21478216
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term effects of aerosolised rhDNase on pulmonary disease progression in patients with cystic fibrosis.
    Milla CE
    Thorax; 1998 Dec; 53(12):1014-7. PubMed ID: 10195070
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects.
    Lenney W; Edenborough F; Kho P; Kovarik JM
    J Cyst Fibros; 2011 Jan; 10(1):9-14. PubMed ID: 20884302
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recombinant human DNase (rhDNase) influences phospholipid composition, surface activity, rheology and consecutively clearance indices of cystic fibrosis sputum.
    Griese M; App EM; Duroux A; Burkert A; Schams A
    Pulm Pharmacol Ther; 1997; 10(1):21-7. PubMed ID: 9344829
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group.
    O'Donnell AE; Barker AF; Ilowite JS; Fick RB
    Chest; 1998 May; 113(5):1329-34. PubMed ID: 9596315
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems. Aerosolized Tobramycin Study Group.
    Eisenberg J; Pepe M; Williams-Warren J; Vasiliev M; Montgomery AB; Smith AL; Ramsey BW
    Chest; 1997 Apr; 111(4):955-62. PubMed ID: 9106575
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nebulized hypertonic saline and recombinant human DNase in the treatment of pulmonary atelectasis in newborns.
    Dilmen U; Karagol BS; Oguz SS
    Pediatr Int; 2011 Jun; 53(3):328-31. PubMed ID: 20831650
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of rhDNase therapy and costs of respiratory-related care in patients with cystic fibrosis.
    Ollendorf DA; McGarry LJ; Watrous ML; Oster G
    Ann Pharmacother; 2000 Mar; 34(3):304-8. PubMed ID: 10917374
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Statistical analysis of the long-term effects of recombinant human deoxyribonuclease on pulmonary function in cystic fibrosis patients.
    Chen JJ; Hamilton SA
    J Biopharm Stat; 2000 Aug; 10(3):287-97. PubMed ID: 10959912
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Aerosolized dornase alfa in cystic fibrosis: is there a role in the management of patients with early obstructive lung disease?
    Geller DE
    Pediatr Pulmonol; 1997 Aug; 24(2):155-8; discussion 159-61. PubMed ID: 9292913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.